Research Library
Peer-reviewed papers from top journals, summarized and graded by evidence strength. Updated Mon, Wed & Fri.
6 papers added this week271 in the library
| Study | Evidence | Type | n | Journal | Date |
|---|---|---|---|---|---|
| Jul 13–19, 20261 study | |||||
| NMN Protected Rat Testes From Chemotherapy Damage in Early StudyThe chemo drug doxorubicin badly damages the testes, a real worry for male cancer patients. | Preliminary | Journal Article | 32 | Molecular biology reports | |
| Jun 29 – Jul 5, 20261 study | |||||
| Astaxanthin Protected Mouse Ovaries From Chemo DamageChemotherapy can push younger women into early ovarian failure. | Preliminary | Journal Article | — | Journal of ovarian research | |
| Jun 8–14, 20261 study | |||||
| How a Common Chemo Drug Eats Away at Muscle, and a Possible Way to Block ItCisplatin is a widely used cancer drug, but it often wastes away muscle. | Preliminary | Journal Article | — | Cell communication and signaling : CCS | |
Jun 29 – Jul 5, 2026
1 studyDisclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Common questions
What is the Longevity Research Library?
The Longevity Austria Research Library curates recent peer-reviewed studies on longevity, nutrition, exercise, sleep, and supplements. Each study is rated by evidence strength: Strong, Moderate, or Preliminary.
How are evidence levels determined?
Evidence levels are based on study type (meta-analysis, RCT, cohort study), sample size, journal impact factor, and reproducibility of findings.
Your Weekly Edge
Receive the latest longevity insights, exclusive event invites, and science-backed tips to help you live longer and thrive.
